John P Stone1, Hannah Sevenoaks2, Trygve Sjöberg3, Stig Steen3, Nizar Yonan1, James E Fildes4. 1. Transplant Centre, University Hospital of South Manchester; Manchester Collaborative Centre for Inflammation Research, Core Technology Facility, Institute of Inflammation and Repair, University of Manchester, Manchester, UK. 2. Transplant Centre, University Hospital of South Manchester. 3. Department of Cardiothoracic Surgery, Lund University and Skåne University Hospital, Lund, Sweden. 4. Transplant Centre, University Hospital of South Manchester; Manchester Collaborative Centre for Inflammation Research, Core Technology Facility, Institute of Inflammation and Repair, University of Manchester, Manchester, UK. Electronic address: james.fildes@manchester.ac.uk.
Abstract
BACKGROUND: Ex vivo lung perfusion (EVLP) is a novel procedure designed to rapidly assess and recondition unusable donor lungs for transplantation (LTx). EVLP may reduce graft immunogenicity and allorecognition via removal of passenger leukocytes. We aimed to explore this hypothesis using human EVLP and in vitro analysis. METHODS: Explanted human lungs (n = 7) underwent standard EVLP. Perfusate samples and the leukocyte filter were collected, and cells characterized via flow cytometry. Isolated alveolar monocytes (from post-LTx bronchoalveolar lavage) were differentiated to dendritic cells and characterized (n = 10). An in vitro (air epithelial-liquid endothelial) lung model was utilized to evaluate monocyte migration and differentiation within the lung. RESULTS: Non-classical monocytes (NCM, normally <1% of total white blood cell repertoire) mobilized within 30 minutes of EVLP and represented 80.04% of the passenger leukocyte population. This subset readily differentiated to dendritic cells and secreted pro-inflammatory cytokines (interferon-γ and interleukin-2) after stimulation. NCM rapidly diapedesed from the vascular bed to the alveolus and, when cultured on the alveolus, differentiated to dendritic cells with inflammatory phenotypes. CONCLUSIONS: The lung possesses a reservoir of NCM, which can readily diapedese to the alveolus or mobilize in the circulation. After activation, NCM differentiate to inflammatory dendritic cells with T-cell co-stimulatory capacity. EVLP may impart additional benefits after LTx via the removal of passenger monocytes, which may represent a previously unidentified beneficial mechanism of action.
BACKGROUND: Ex vivo lung perfusion (EVLP) is a novel procedure designed to rapidly assess and recondition unusable donor lungs for transplantation (LTx). EVLP may reduce graft immunogenicity and allorecognition via removal of passenger leukocytes. We aimed to explore this hypothesis using human EVLP and in vitro analysis. METHODS: Explanted human lungs (n = 7) underwent standard EVLP. Perfusate samples and the leukocyte filter were collected, and cells characterized via flow cytometry. Isolated alveolar monocytes (from post-LTx bronchoalveolar lavage) were differentiated to dendritic cells and characterized (n = 10). An in vitro (air epithelial-liquid endothelial) lung model was utilized to evaluate monocyte migration and differentiation within the lung. RESULTS: Non-classical monocytes (NCM, normally <1% of total white blood cell repertoire) mobilized within 30 minutes of EVLP and represented 80.04% of the passenger leukocyte population. This subset readily differentiated to dendritic cells and secreted pro-inflammatory cytokines (interferon-γ and interleukin-2) after stimulation. NCM rapidly diapedesed from the vascular bed to the alveolus and, when cultured on the alveolus, differentiated to dendritic cells with inflammatory phenotypes. CONCLUSIONS: The lung possesses a reservoir of NCM, which can readily diapedese to the alveolus or mobilize in the circulation. After activation, NCM differentiate to inflammatory dendritic cells with T-cell co-stimulatory capacity. EVLP may impart additional benefits after LTx via the removal of passenger monocytes, which may represent a previously unidentified beneficial mechanism of action.
Authors: Maria Lucia L Madariaga; Sebastian G Michel; Glenn M La Muraglia; Smita Sihag; David A Leonard; Evan A Farkash; Robert B Colvin; Curtis L Cetrulo; Christene A Huang; David H Sachs; Joren C Madsen; James S Allan Journal: Transplantation Date: 2015-07 Impact factor: 4.939
Authors: Ruta Zulpaite; Povilas Miknevicius; Bettina Leber; Kestutis Strupas; Philipp Stiegler; Peter Schemmer Journal: Front Med (Lausanne) Date: 2021-12-24
Authors: Andy Chao Hsuan Lee; Arianna Edobor; Maria Lysandrou; Vikranth Mirle; Amir Sadek; Laura Johnston; Ryan Piech; Rebecca Rose; John Hart; Beth Amundsen; Martin Jendrisak; James Michael Millis; Jessica Donington; Maria Lucia Madariaga; Rolf N Barth; Diego di Sabato; Kumaran Shanmugarajah; John Fung Journal: Front Immunol Date: 2022-06-02 Impact factor: 8.786
Authors: Mindaugas Kvietkauskas; Bettina Leber; Kestutis Strupas; Philipp Stiegler; Peter Schemmer Journal: Front Immunol Date: 2020-02-27 Impact factor: 7.561
Authors: Robert P Davis; John Yerxa; Qimeng Gao; Jared Gloria; Uwe Scheuermann; Mingqing Song; Min Zhang; William Parker; Jaewoo Lee; Matthew G Hartwig; Andrew S Barbas Journal: Transplant Direct Date: 2020-02-10